Identifying Needs and Opportunities to Improve Clinical Outcomes in the Identification, Characterization, and Management of Low-Grade Serous Ovarian Cancer
Released On
July 15, 2024
Expires On
July 15, 2025
Media Type
Internet
Completion Time
45 minutes
Specialty
Hematology-Oncology
Topic(s)
Oncology, Ovarian Cancer
This activity is provided by Med Learning Group.
This activity is supported by an educational grant from Verastem Inc.
Credit Available
- Physicians — maximum of 0.75 AMA PRA Category 1 Credit™
- Nurses — 0.75 Nursing Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of oncologists, obstetrician/gynecologists, gastroenterologists, and primary care physicians to ensure confidence in the diagnosis, characterization, and management of low-grade serous ovarian cancer, including through enrollment in ongoing clinical trials.
Program Overview
This enduring educational activity will provide insight into evidence-based approaches for clinical and pathological assessment of patients with demonstrated/suspected low-grade serous ovarian cancer (LGSOC). It will also present efficacy and safety considerations for available therapeutic options in the management of LGSOC and the latest evidence regarding novel targeted treatments for this condition, incorporating a detailed look at the clinical rational for RAF, MEK, and FAK inhibition.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize the need for improved diagnosis and recognition of the clinical and genomic features of low-grade serous ovarian cancer (LGSOC) to better address disease burden
- Review efficacy and safety data for available therapeutic options in the management of LGSOC and needs for novel targeted management
- Analyze the latest clinical data informing the safety and efficacy of novel targeted treatments—including RAF, MEK, and FAK—for the clinical management of LGSOCs
Faculty
Premal H. Thaker, MD, MS
David and Lynn Mutch Distinguished Professor of Obstetrics and Gynecology
Chief of Gynecologic Oncology (Interim)
Director of Gynecologic Oncology Clinical Research
Professor in Gynecologic Oncology
Washington University School of Medicine
St. Louis, MO
Joint Accreditation Statement
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement
Med Learning Group designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™ Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Disclosure of Relevant Financial Relationships
- Premal H. Thaker, MD
- Consulting fees: AstraZeneca, Glaxo Smith Kline, Novocure, Verastem, Zentalis, Immunogen, Immunon, Merck, Iovance, Eisai and Caris.
- Contracted research: Merck and Glaxo Smith Kline.
- Ownership interest: Immunon
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
A medical reviewer from CME Peer Review LLC, has nothing to disclose.
Sarah Milano, RD, MSN, has nothing to disclose.
Robert Geist, Medical Director for Med Learning Group, has nothing to disclose.
Ana Maria Albino, Senior Program Manager for Med Learning Group, has nothing to disclose.
Jessica Feygin-Samuels, Associate Program Manager for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Manager of Med Learning Group, has nothing to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
Contact Information
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Content - Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
